HomeGENX • CVE
add
Genix Pharmaceuticals Corp
Previous close
$0.030
Year range
$0.020 - $0.090
Market cap
1.78M CAD
Avg Volume
7.41K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.46K | -21.44% |
Net income | -51.98K | 39.52% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -31.18K | 18.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.30K | -54.94% |
Total assets | 41.67K | -83.15% |
Total liabilities | 1.38M | -9.52% |
Total equity | -1.34M | — |
Shares outstanding | 59.22M | — |
Price to book | -1.50 | — |
Return on assets | -160.24% | — |
Return on capital | 20.71% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -51.98K | 39.52% |
Cash from operations | -14.24K | 75.65% |
Cash from investing | — | — |
Cash from financing | 15.36K | -73.85% |
Net change in cash | 1.12K | 349.40% |
Free cash flow | -49.75K | -20.58% |
About
Founded
1993
Headquarters
Website
